Your browser doesn't support javascript.
loading
Archetype JC polyomavirus DNA associated with extracellular vesicles circulates in human plasma samples.
Scribano, Stefano; Guerrini, Mirko; Arvia, Rosaria; Guasti, Daniele; Nardini, Patrizia; Romagnoli, Paolo; Giannecchini, Simone.
Afiliación
  • Scribano S; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Guerrini M; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Arvia R; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Guasti D; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Nardini P; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Romagnoli P; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Giannecchini S; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: simone.giannecchini@unifi.it.
J Clin Virol ; 128: 104435, 2020 07.
Article en En | MEDLINE | ID: mdl-32442760
BACKGROUND: JC polyomavirus (JCPyV) establishes a stable and successful interaction with the host, causing progressive multifocal leukoencephalopathy (PML) in immunocompromised subjects. Recently, it has been reported that JCPyV, like other viruses, may exploit extracellular vesicles (EV) in cell cultures. OBJECTIVE: To investigate the presence of JCPyV-DNA in EV circulating in human plasma obtained from patients at risk for PML. STUDY DESIGN: JCPyV-DNA status was studied in EV obtained from 170 plasma samples collected from 120 HIV positive patients and 50 healthy donors. EV were extracted from plasma and characterized by Nanoparticle tracking analysis, by western blot for presence of tetraspanin CD63, CD81, annexin II, cythocrome C protein and, finally, by immunoelectron microscopy (IEM). Presence and quantitation of JCPyV-DNA were assessed with Multiplex real-time TaqMan PCR assay. RESULTS: The JCPyV-DNA plasma prevalence in 120 HIV positive patients and 50 healthy donors was 28% and 4%, respectively. The investigation performed on well-characterized plasma EV reported JCPyV-DNA detection in 15 out of 36 (42%) of the viremic samples (14 were from HIV patients and 1 from healthy people) at a mean level of 23.5 copies/mL. The examination of EV selected samples reported the percentage of JCPyV-DNA in EV of 5.4% of the total viral load. Moreover, IEM reported the presence of JCPyV Vp1 antigen in plasma-derived EV. CONCLUSION: The potential role of EV-associated JCPyV-DNA open new avenues and mechanistic insights into the molecular strategies adopted by this polyomavirus to persist in the host and spread to the central nervous system.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Plasma / ADN Viral / Virus JC / Vesículas Extracelulares Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: J Clin Virol Asunto de la revista: VIROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Plasma / ADN Viral / Virus JC / Vesículas Extracelulares Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: J Clin Virol Asunto de la revista: VIROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Países Bajos